From Name:
From Email:
To Name:
To Email:

Optional Message:

Hydrocodone combination products rescheduling takes effect Oct. 6

from AzPA

The DEA's final rule on rescheduling hydrocodone combination products (HCPs) into Controlled Substance Schedule II takes effect Oct. 6. To help pharmacists prepare and discuss the coming change with prescribers and patients, NCPA has prepared a summary of the final rule as well as information for prescribers and pharmacists and a letter that pharmacists can personalize and distribute to their patients.

Key Points
Patient Letter

The DEA recently released a long-awaited final rule to govern controlled-substances take-back programs, one that offers consumers options but no incentives for pharmacies to participate. DEA addressed several of NCPA's long-term care-related concerns, and it's important to note the program is completely voluntary for both retail and LTC pharmacies — as NCPA requested and the law required. The good news for LTC is that the facilities can continue to employ current methods of destruction, as applicable by law. NCPA has prepared an initial analysis of the rule. Most state pharmacy practice acts do not specifically address prescription medication take-back programs for disposal. Should you have specific questions, check directly with your Board of Pharmacy to ensure that you are in full compliance with your respective state pharmacy regulations. DEA issued fact sheets on the rule as well. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063